Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Minority Interest (2018 - 2021)

Amphastar Pharmaceuticals has reported Minority Interest over the past 4 years, most recently at $45.2 million for Q2 2021.

  • For Q2 2021, Minority Interest changed N/A year-over-year to $45.2 million; the TTM value through Jun 2021 reached $45.2 million, changed N/A, while the annual FY2020 figure was $46.4 million, 0.55% up from the prior year.
  • Minority Interest for Q2 2021 was $45.2 million at Amphastar Pharmaceuticals, roughly flat from $45.4 million in the prior quarter.
  • Over five years, Minority Interest peaked at $46.4 million in Q4 2020 and troughed at $21.9 million in Q3 2018.
  • A 4-year average of $42.0 million and a median of $45.3 million in 2019 define the central range for Minority Interest.
  • Biggest five-year swings in Minority Interest: surged 102.47% in 2019 and later fell 1.0% in 2021.
  • Year by year, Minority Interest stood at $31.9 million in 2018, then surged by 44.6% to $46.2 million in 2019, then increased by 0.55% to $46.4 million in 2020, then fell by 2.56% to $45.2 million in 2021.
  • Business Quant data shows Minority Interest for AMPH at $45.2 million in Q2 2021, $45.4 million in Q1 2021, and $46.4 million in Q4 2020.